Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hepatic Veno-Occlusive Disease

• Defibrotide Dose-escalation for SOS Post-HSCT
• Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation
• 5-day Defibrotide Treatment for Hepatic SOS/VOD
• Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients
• Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
• Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation
• Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
• Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients
• Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients
• Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide
• Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver
• Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver